Treatment failure and emotional well-being in multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This study looks at how a failed treatment affects the emotional and social experiences of people with relapsing-remitting MS. If you qualify, you'll be asked to complete questionnaires about your feelings and daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have relapsing-remitting multiple sclerosis (RRMS) as per the McDonald 2024 criteria.
- You must have been on a moderately effective treatment continuously for at least 6 months, or a highly effective treatment as your first treatment for at least 6 months.
- You must not have been on the same treatment for 3 years or more.
- You must not have taken a second-line treatment or immunosuppressant before your first-line treatment.
- You cannot be pregnant or breastfeeding, and you must be able to fill out questionnaires on your own.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simple questionnaire that a nurse will ask you during regular check-ups to help spot signs of an MS relapse early. The goal is to see if this tool makes it easier for you and your care team to manage your MS and catch problems sooner.
This study looks at whether MS relapses happen without any signs of new disease activity on an MRI scan. By tracking your symptoms and scans, researchers hope to better understand how MS affects people in real life. If you qualify, you may help improve future treatment decisions.
This study looks at how certain brain changes relate to disability in people with multiple sclerosis (MS). It aims to see if measuring brain volume loss can help predict disease progression, which might help tailor treatments.
This study looks at “subclinical markers,” meaning early or hidden body changes that may show how relapsing-remitting multiple sclerosis (MS) is doing even when symptoms seem mild. It may help researchers find better ways to monitor MS and detect changes sooner.
This trial tests a comprehensive rehabilitation programme for people with multiple sclerosis to see if it can improve their physical abilities and quality of life. Participants will attend regular physiotherapy sessions and undergo clinical and MRI examinations to track changes.
This study follows people with multiple sclerosis over time to learn more about the disease and improve care. If you join, you will help researchers understand MS better, which could lead to better treatments.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.